AGP Picks
View all

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on September 14, 2026

From Signal to Epiphany Explores How the Moments We Can't Forget May Be Trying to Tell Us Something
Etienna Bio Completes FDA INTERACT Meeting for ETB-001
WCLC 2026 | Leads Biolabs’ Opamtistomig (LBL-024) Oral Presentation Demonstrates Robust Response and PFS Benefits in First‑Line NSCLC
Zoom Got It Done: Company’s New Ad Campaign Featuring Kate McKinnon Shows How Zoom Turns Conversations into Completed Work
The Elmet Group to Deploy Strategic Capital to Strengthen U.S. and Allied Tungsten Supply Chain
Department of War Makes Landmark $450 Million Committed Investment in The Elmet Group to Secure America’s Tungsten Supply Chain
Fresh Inset Expands MaTri® System, Putting 1-MCP Treatment Verification in Growers’ Hands
"بركز" تحصل على تمويل بقيمة 31 مليون دولار لتسريع نمو حلول شراء مواد البناء المدعومة بالذكاء الاصطناعي في السعودية ودول الخليج
BRKZ Secures $31 Million to Scale AI-Enabled Building Materials Procurement Across Saudi Arabia and the GCC
Digital Realty Enters Türkiye Through Formation of New Joint Venture
ZEISS VersaXRM 5 Insight beschleunigt hybrides 3D-Röntgen-Imaging
ZEISS VersaXRM 5 Insight accelerates hybrid 3D X-ray imaging
Clarios, Altris and InoBat Advance Sodium-Ion Technology Toward Industrialization
Clarios brings actionable battery intelligence to European fleet operations
BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients
Bio Usawa and Axmed Partner to Expand Access to Affordable Biologic Medicines Across Africa
Neue Daten zu Gotistobart zeigten annähernde Verdopplung des medianen Gesamtüberlebens im Vergleich zur Standardchemotherapie bei Patientinnen und Patienten mit zuvor behandeltem Plattenepithelkarzinom der Lunge
TSplus Named a Top 100 Publisher in ComponentSource Awards 2026
Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company
Cellectis annonce sa transformation stratégique en société d'édition du génome in vivo

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.